Suppr超能文献

[门静脉高压性胃病和结肠病]

[Portal hypertensive gastropathy and colopathy].

作者信息

Ohashi K, Orihata G, Ohta S, Takamori S, Kojima K, Fukazawa M, Beppu T, Futagawa S

机构信息

Second Department of Surgery, Juntendo University, Faculty of Medicine.

出版信息

Nihon Rinsho. 1998 Sep;56(9):2369-75.

PMID:9780722
Abstract

Gastrointestinal bleeding in patients with portal hypertension is usually secondary to esophageal varices, but massive bleeding from gastric mucosal lesions and colonic mucosal lesions including colorectal varices, have been variably described. These lesions are called portal hypertensive gastropathy and colopathy. The incidence and profile of portal hypertensive gastropathy (PHG) has been frequently reported during the last decade, and many studies showed that development of PHG is influenced by coexisting esophageal varices, absence of major portal systemic shunts, severity of liver disease and sclerotherapy and is directly correlated with portal venous pressure. Although hyperdynamic congestion seems to be the underlying mechanisms for the development of PHG, results of gastric mucosal blood flow in patients with PHG is controversial. The treatment can be currently recommended to prevent bleeding, is oral administration of propranolol which decreased portal venous pressure. The clinical feature and profile of portal hypertensive colopathy is classified two groups, which are named colorectal varices and colonic mucosal lesions including vascular spider, dilated fine branching vessels. Although colorectal varices are usually seen at rectum and sigmoid colon, colonic mucosal lesions are seen all part of colon. Significant relationship between colorectal varices and liver disease has been reported and colorectal varices is highly appeared in patients with extrahepatic portal obstruction. Such patients are revealed arteriovenous communications at angiogram. In general, colonic resection or transanal ligation should be the first option for treatment of bleeding colonic varices and colonic mucosal lesions. Transendoscopic sclerotherapy may be an alternate choice.

摘要

门静脉高压患者的胃肠道出血通常继发于食管静脉曲张,但胃黏膜病变和结肠黏膜病变(包括结肠直肠静脉曲张)引起的大出血也有不同程度的报道。这些病变被称为门静脉高压性胃病和结肠病。在过去十年中,门静脉高压性胃病(PHG)的发病率和特征经常被报道,许多研究表明,PHG的发生受并存的食管静脉曲张、主要门静脉系统分流的缺失、肝脏疾病的严重程度以及硬化治疗的影响,并且与门静脉压力直接相关。尽管高动力性充血似乎是PHG发生的潜在机制,但PHG患者胃黏膜血流的结果存在争议。目前推荐用于预防出血的治疗方法是口服普萘洛尔,它可降低门静脉压力。门静脉高压性结肠病的临床特征和表现分为两组,分别称为结肠直肠静脉曲张和结肠黏膜病变(包括血管蜘蛛痣、扩张的细分支血管)。尽管结肠直肠静脉曲张通常见于直肠和乙状结肠,但结肠黏膜病变可见于结肠的所有部位。已有报道结肠直肠静脉曲张与肝脏疾病之间存在显著关系,并且结肠直肠静脉曲张在肝外门静脉阻塞患者中高度出现。此类患者在血管造影中显示有动静脉交通。一般来说,结肠切除术或经肛门结扎术应是治疗出血性结肠静脉曲张和结肠黏膜病变的首选方法。经内镜硬化治疗可能是一种替代选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验